1h-tetrazole has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Furukawa, S; Ito, Y; Kitao, T; Morishita, K; Shirahase, H; Yamamoto, M | 1 |
| Ikeda, H; Maekawa, T; Momose, Y; Odaka, H; Sohda, T | 1 |
2 other study(ies) available for 1h-tetrazole and Obesity
| Article | Year |
|---|---|
Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
Topics: 3T3-L1 Cells; Adipogenesis; Adiponectin; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Hypoglycemic Agents; Lipid Metabolism; Male; Mice; Mice, Transgenic; Obesity; Pioglitazone; PPAR gamma; Rats; Tetrazoles; Triglycerides; Weight Gain | 2021 |
Novel 5-substituted-1H-tetrazole derivatives as potent glucose and lipid lowering agents.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Mice, Inbred Strains; Obesity; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Tetrazoles; Transcription Factors; Triglycerides | 2002 |